Revised International Staging System (R-ISS) for Multiple Myeloma

ورودی‌های بالینی بیمار

حداقل ۱ — حداکثر ۳

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
riss stage
—stage
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

Direct Clinical Answer

The Revised International Staging System (R-ISS) for Multiple Myeloma calculates determining thromboembolic risk, heparin-induced thrombocytopenia probability, and bleeding diathesis. Key inputs include iss stage. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Myeloma staging combining ISS, LDH and high-risk cytogenetics.

Clinical Indication

The Revised International Staging System (R-ISS) for Multiple Myeloma is indicated for bedside clinical practice to support Myeloma staging combining ISS, LDH and high-risk cytogenetics.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.

Limitations & Contraindications

Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.

Clinical Pearls & Action Plan

Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies.

Formula & Variables:

R-ISS I: ISS I + normal LDH + standard-risk CA. R-ISS III: ISS III + (high LDH or high-risk CA). R-ISS II: neither

Input Parameters

NameTypeRequiredDescription
iss_stageintegerYesISS stage (1-3)
ldh_highbooleanYesLDH above upper limit of normal
high_risk_cytogeneticsbooleanYesHigh-risk cytogenetics [del(17p), t(4;14), t(14;16)]

Evidence-Based References (EBM)

  • Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised International Staging System for multiple myeloma. J Clin Oncol. 2015;33(26):2863-2869.

Related calculators